apt12279-sup-FigS1-S6.docxWord document257K

Figure S1. Pentoxifylline vs. placebo, 28-day mortality.

Figure S2. Pentoxifylline vs. placebo, incidence of fatal HRS.

Figure S3. Pentoxifylline vs. prednisolone, 28-day survival.

Figure S4. Pentoxifylline vs. combination therapy, 28-day survival.

Figure S5. Pentoxifylline vs. combination therapy, 6-month survival.

Figure S6. Pentoxifylline vs. combination therapy, incidence of HRS.

apt12279-sup-TableS1-S3.docxWord document154K

Table S1. Quality of trials published as full manuscripts assessed by CONSORT criteria.

Table S2. Quality of trials published as abstracts assessed by CONSORT guidelines.

Table S3. Outcomes: 28-day mortality, 6-month mortality and incidence of HRS (%) (analysed with Fisher's exact test).

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.